[CU6] YoY Quarter Result on 31-Mar-2020 [#Q3]

Stock
[CU6] Clarity Pharmaceuticals Ltd
Announcement Date
30-Mar-2020
Financial Year
2020
Quarter
31-Mar-2020 [#Q3]
Profit Trend
QoQ- 44.51%
YoY-
Quarter Report
CU6's Result
CU6's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 CAGR
Revenue 3,044 2,034 1,826 932 790 40.07%
PBT -12,466 -6,657 -5,015 -2,683 -1,829 61.52%
Tax 95 23 6 0 0 -
NP -12,561 -6,680 -5,021 -2,683 -1,829 61.83%
Tax Rate - - - - - -
Total Cost 15,605 8,714 6,847 3,615 2,618 56.20%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 CAGR
NP Margin -412.61 -328.42 -275.00 -287.76 -231.60 15.52%
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 CAGR
EPS -0.04 -0.03 -0.02 -0.01 -0.01 41.38%
EPS Diluted -0.04 -0.03 -0.02 -0.01 -0.01 41.38%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.